It is reported that DUSP14 knockout aggravated pathological processes involved in non-alcoholic fatty liver disease development, whereas DUSP14 overexpression ameliorated these pathological alterations (Wang S. et al., 2018). Here, DUSP14 is linked to metabolic dysfunction-associated steatotic liver disease.